x

Tempest Therapeutics, Inc. (Nasdaq:TPST)

Health Care/Life Sciences • Biotechnology
CIK 1544227
Company

Tempest Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.

Address
2000 Sierra Point Parkway
Suite 400
Brisbane, California 94005
Employees
19
Stock Info
Close
$3.1700
Day Range
3.0900 - 3.2900
52 Week Range
0.1700 - 9.7700
Average volume
912.92K
Short Interest
870.37K (02/15/24)
% of Float Shorted
5.44%
Market Cap
$60.82M
Revenue
N/A
Net Income
-$35.71M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$2.4383
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
President, Chief Executive Officer & Director
Stephen R Brady
Chairman
Michael G Raab
Independent Director
Geoffrey M Nichol MD, MBA
Independent Director
Christine A Pellizzari
Independent Director
Ronit Simantov MD
SEC filings
DateFormEvent
6 Dec, 2024 8-K
12 Nov, 2024 DEF 14A
12 Nov, 2024 10-Q
12 Nov, 2024 8-K
29 Oct, 2024 PRE 14A
10 Oct, 2024 8-A12B/A
10 Oct, 2024 8-K
13 Aug, 2024 144
12 Aug, 2024 SC 13D/A
12 Aug, 2024 4
9 Aug, 2024 144
8 Aug, 2024 10-Q
8 Aug, 2024 8-K
19 Jul, 2024 S-3
8 Jul, 2024 4
3 Jul, 2024 4
2 Jul, 2024 4
20 Jun, 2024 424B5
20 Jun, 2024 8-K
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 4
14 Jun, 2024 8-K
14 Jun, 2024 4
13 May, 2024 SC 13D/A
9 May, 2024 10-Q
9 May, 2024 8-K
23 Apr, 2024 ARS
23 Apr, 2024 DEFA14A
23 Apr, 2024 DEF 14A
19 Mar, 2024 S-8
19 Mar, 2024 10-K
19 Mar, 2024 8-K
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G/A
9 Feb, 2024 SC 13G/A
8 Feb, 2024 SC 13D/A
5 Jan, 2024 4
5 Jan, 2024 4
5 Jan, 2024 4
5 Jan, 2024 4
17 Nov, 2023 S-8 POS
17 Nov, 2023 S-8 POS
17 Nov, 2023 S-8 POS
17 Nov, 2023 S-8 POS
17 Nov, 2023 S-8 POS
17 Nov, 2023 S-8
9 Nov, 2023 SC 13D/A
8 Nov, 2023 10-Q
8 Nov, 2023 8-K
2 Nov, 2023 144
30 Oct, 2023 8-K
13 Oct, 2023 4
13 Oct, 2023 4
13 Oct, 2023 4
13 Oct, 2023 4
12 Oct, 2023 424B5
11 Oct, 2023 8-A12B
11 Oct, 2023 8-K
8 Sep, 2023 8-K
7 Sep, 2023 8-K CEO Change
10 Aug, 2023 8-K
10 Aug, 2023 10-Q
16 Jun, 2023 8-K
10 May, 2023 10-Q
10 May, 2023 8-K
1 May, 2023 DEFA14A
1 May, 2023 DEF 14A
1 May, 2023 ARS
28 Apr, 2023 8-K
31 Mar, 2023 8-K
22 Mar, 2023 8-K
22 Mar, 2023 10-K
14 Feb, 2023 SC 13G/A
14 Feb, 2023 SC 13G
5 Jan, 2023 4
5 Jan, 2023 4
5 Jan, 2023 4
5 Jan, 2023 4
5 Jan, 2023 4
29 Dec, 2022 8-K
8 Nov, 2022 10-Q
8 Nov, 2022 8-K
4 Oct, 2022 3
4 Oct, 2022 4
23 Sep, 2022 8-K
15 Aug, 2022 8-K
15 Aug, 2022 10-Q
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
22 Jun, 2022 4
21 Jun, 2022 S-8
21 Jun, 2022 8-K
9 Jun, 2022 8-K
27 May, 2022 424B3
27 May, 2022 EFFECT
26 May, 2022 8-K
26 May, 2022 DEFA14A
24 May, 2022 CORRESP
18 May, 2022 UPLOAD
16 May, 2022 S-3
13 May, 2022 S-8
13 May, 2022 8-K
13 May, 2022 10-Q
11 May, 2022 D
9 May, 2022 SC 13D
9 May, 2022 DEFA14A
9 May, 2022 DEFA14A
3 May, 2022 3
3 May, 2022 4
3 May, 2022 4
2 May, 2022 DEFA14A
2 May, 2022 8-K
2 May, 2022 DEF 14A
22 Apr, 2022 PRE 14A
14 Apr, 2022 424B5
1 Apr, 2022 10-K/A
29 Mar, 2022 10-K
29 Mar, 2022 8-K
17 Feb, 2022 SC 13G
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
14 Feb, 2022 SC 13G/A
11 Feb, 2022 SC 13G
11 Jan, 2022 4
10 Jan, 2022 3
10 Jan, 2022 4
6 Jan, 2022 4
6 Jan, 2022 4
6 Jan, 2022 4
6 Jan, 2022 4
6 Jan, 2022 4
3 Jan, 2022 SC 13G
23 Dec, 2021 8-K
10 Nov, 2021 8-K
10 Nov, 2021 10-Q
30 Sep, 2021 8-K/A
24 Sep, 2021 8-K
23 Sep, 2021 4
20 Sep, 2021 4/A
20 Sep, 2021 4/A
20 Sep, 2021 4/A
20 Sep, 2021 4/A
12 Aug, 2021 10-Q
12 Aug, 2021 8-K
10 Aug, 2021 3
10 Aug, 2021 4
23 Jul, 2021 424B5
23 Jul, 2021 8-K
23 Jul, 2021 EFFECT
22 Jul, 2021 CORRESP
21 Jul, 2021 UPLOAD
16 Jul, 2021 S-3
16 Jul, 2021 8-K
15 Jul, 2021 SC 13G/A
14 Jul, 2021 4
14 Jul, 2021 3
12 Jul, 2021 8-K
8 Jul, 2021 SC 13G
7 Jul, 2021 8-K
7 Jul, 2021 S-8
6 Jul, 2021 3
6 Jul, 2021 SC 13G
6 Jul, 2021 4
6 Jul, 2021 4
6 Jul, 2021 4
6 Jul, 2021 4
6 Jul, 2021 3
1 Jul, 2021 8-K/A
30 Jun, 2021 4
30 Jun, 2021 3
29 Jun, 2021 4
29 Jun, 2021 4
29 Jun, 2021 4
29 Jun, 2021 4
29 Jun, 2021 4
29 Jun, 2021 4
29 Jun, 2021 3
29 Jun, 2021 3
29 Jun, 2021 3
29 Jun, 2021 3
29 Jun, 2021 3
29 Jun, 2021 3
28 Jun, 2021 8-K CEO Change
23 Jun, 2021 8-K
11 Jun, 2021 425
11 Jun, 2021 8-K
13 May, 2021 10-Q
11 May, 2021 424B3
11 May, 2021 EFFECT
10 May, 2021 S-4/A
7 May, 2021 CORRESP
4 May, 2021 S-4/A
29 Apr, 2021 10-K/A
16 Apr, 2021 UPLOAD
15 Apr, 2021 S-8
13 Apr, 2021 SC 13D/A
13 Apr, 2021 S-4
7 Apr, 2021 SC 13G
29 Mar, 2021 8-K
29 Mar, 2021 10-K
29 Mar, 2021 425
19 Mar, 2021 4
16 Mar, 2021 SC 13G
2 Mar, 2021 4
2 Mar, 2021 4
16 Feb, 2021 SC 13G/A
16 Feb, 2021 SC 13G/A
9 Feb, 2021 3
28 Jan, 2021 8-K CEO Change
5 Jan, 2021 8-K
Last update:2024-03-06 13:43:06.329267
Tempest Therapeutics, Inc. by TradingView

Sign Up to Subscribe